MIR328 is a microRNA implicated in various cellular processes and disease states [PMC7912829]. It has been identified as a regulator of gene expression, including the regulation of GNG7 expression, potentially through a common upstream factor shared with miR15a [PMC2361448]. In chronic myeloid leukemia (CML) cell lines, the knockdown of endogenous MIR328 has been associated with increased resistance to the drug imatinib, whereas increasing MIR328 levels through exosomal delivery can sensitize these cells to the treatment [PMC7912829]. MIR328 is also reported to regulate untranslated PIM1 and other PIM kinases, which are involved in cell survival and proliferation [PMC8125027]. Furthermore, MIR328 interacts with various biomolecules including protein-coding genes and other non-coding RNAs as identified by its interaction with HNRNPK [PMC9730017]. In pathological conditions such as kidney disease and heart valve disease, MIR328 levels have been found to be altered, suggesting its role in these diseases' progression [PMC4068774], [PMC7197751]. Additionally, MIR328 has been studied for its potential as a biomarker in traumatic brain injury (TBI), highlighting its diagnostic relevance in neurology [PMC7327940].
---u g A U agaaagu a gga uGGGGGGGCAGG GGGGC CAGGG gc u ||| |||||||||||| ||||| ||||| || a ccU GCCUUCCCGUCU UCCCG GUCcc cg c gucc - C - ------- a
Accession | MIMAT0000752 |
Description | Homo sapiens hsa-miR-328-3p mature miRNA |
Sequence | 48 - CUGGCCCUCUCUGCCCUUCCGU - 69 |
Evidence |
experimental
cloned [3], Illumina [4] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() |
Accession | MIMAT0026486 |
Description | Homo sapiens hsa-miR-328-5p mature miRNA |
Sequence | 7 - GGGGGGGCAGGAGGGGCUCAGGG - 29 |
Evidence |
experimental
Illumina [4] |
|